Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb 8;7(1):e000585.
doi: 10.1136/bmjdrc-2018-000585. eCollection 2019.

Plant-derived polyunsaturated fatty acids and markers of glucose metabolism and insulin resistance: a meta-analysis of randomized controlled feeding trials

Affiliations
Review

Plant-derived polyunsaturated fatty acids and markers of glucose metabolism and insulin resistance: a meta-analysis of randomized controlled feeding trials

Anne J Wanders et al. BMJ Open Diabetes Res Care. .

Abstract

The objective of this meta-analysis was to investigate the effects of plant-derived polyunsaturated fatty acids (PUFAs) on glucose metabolism and insulin resistance. Scopus and PubMed databases were searched until January 2018. Eligible studies were randomized controlled feeding trials that investigated the effects of a diet high in plant-derived PUFA as compared with saturated fatty acids (SFA) or carbohydrates and measured markers of glucose metabolism and insulin resistance as outcomes. Data from 13 relevant studies (19 comparisons of plant-derived PUFA with control) were retrieved. Plant-derived PUFA did not significantly affect fasting glucose (-0.01 mmol/L (95 % CI - 0.06 to 0.03 mmol/L)), but lowered fasting insulin by 2.6 pmol/L (-4.9 to -0.2 pmol/L) and homeostatic model assessment-insulin resistance (HOMA-IR) by 0.12 units (-0.23 to - 0.01 units). In dose-response analyses, a 5% increase in energy (En%) from PUFA significantly reduced insulin by 5.8 pmol/L (95% CI -10.2 to -1.3 pmol/L), but not glucose (change -0.07, 95% CI -0.17 to 0.04 mmol/L) and HOMA-IR (change - 0.24, 95% CI -0.56 to 0.07 units). In subgroup analyses, studies with higher PUFA dose (upper tertiles) reduced insulin (-6.7, -10.5 to -2.9 pmol/L) and HOMA-IR (-0.28, -0.45 to -0.12 units), but not glucose (-0.09, 95% CI -0.18 to 0.01 mmol/L), as compared with an isocaloric control. Subgroup analyses showed no differences in effects between SFA and carbohydrates as replacement nutrients (p interaction ≥0.05). Evidence from randomized controlled trials indicated that plant-derived PUFA as an isocaloric replacement for SFA or carbohydrates probably reduces fasting insulin and HOMA-IR in populations without diabetes.

Keywords: Linoleic acid; dietary fat; glucose metabolism; insulin resistance; meta-analysis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors of this manuscript have the following competing interests: AJW, WAMB, PLZ, MA are employed by Unilever, Vlaardingen, the Netherlands. Unilever markets food products made of vegetable oils such as dressings. Unilever has divested its spreads business, which is since July 2, 2018 operating under the name Upfield™. JMG received research funding from Unilever for studies on fatty acids and cardiovascular disease. IAB supervises a student whose project is partly funded by Unilever.

Figures

Figure 1
Figure 1
Flow chart of study selection. PUFA, polyunsaturated fatty acid.
Figure 2
Figure 2
Forest plots of comparing a diet high in plant-derived PUFA with saturated fatty acids or carbohydrates on absolute changes in fasting glucose (mmol/L), fasting insulin (pmol/L) and HOMA-IR (unit), ordered by PUFA dose (low to high from top to bottom). Pooled estimates are based on fixed and random effects models. HOMA-IR, homeostatic model assessment-insulin resistance; PUFA, poly-unsaturated fatty acids.

Similar articles

Cited by

References

    1. International Diabetes Federation IDF diabetes atlas. 8th edn Brussels, Belgium, 2017.
    1. Schellenberg ES, Dryden DM, Vandermeer B, et al. . Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med 2013;159:543–51. 10.7326/0003-4819-159-8-201310150-00007 - DOI - PubMed
    1. Franz MJ, Powers MA, Leontos C, et al. . The evidence for medical nutrition therapy for type 1 and type 2 diabetes in adults. J Am Diet Assoc 2010;110:1852–89. 10.1016/j.jada.2010.09.014 - DOI - PubMed
    1. Ley SH, Hamdy O, Mohan V, et al. . Prevention and management of type 2 diabetes: dietary components and nutritional strategies. The Lancet 2014;383:1999–2007. 10.1016/S0140-6736(14)60613-9 - DOI - PMC - PubMed
    1. FAO/WHO Fats and fatty acids in human nutrition. Report of an expert consultation. Geneva, 2010. - PubMed